Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Oncotarget|November 21, 2017
Fibroblast growth factor-2-mediated protection of cardiomyocytes from the toxic effects of doxorubicin requires the mTOR/Nrf-2/HO-1 pathwayNavid Koleini, Barbara E Nickel, Jie Wang, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Macrophages Lacking TSC2 have mTORC1-dependent GPNMB Augmentation Ameliorating Cardiac Ischemia-Reperfusion InjuryMohammad Keykhaei, Navid Koleini, Mariam Meddeb, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Depressed Proximal Glycolysis in Myocardium Of Human Heart Failure with Preserved Ejection FractionNavid Koleini, Mariam Meddeb, Mohammad Keykhaei, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|October 29, 2018
Statins: a new approach to combat temozolomide chemoresistance in glioblastomaShahla Shojaei, Javad Alizadeh, James Thliveris, et al.
European Journal of Heart Failure|August 9, 2024
Landscape of glycolytic metabolites and their regulating proteins in myocardium from human heart failure with preserved ejection fractionNavid Koleini, Mariam Meddeb, Liang Zhao, et al.
Journal of Molecular and Cellular Cardiology|October 20, 2024
Cardiomyocyte myofilament function in common animal models of heart failure with preserved ejection fractionVivek P Jani, Navid Koleini, Axel J Fenwick, et al.
Scientific Reports|November 19, 2025
Macrophages lacking TSC2 have mTORC1-dependent increased GPNMB and ameliorate ventricular dysfunction/remodeling after ischemia-reperfusionMohammad Keykhaei, Navid Koleini, Mariam Meddeb, et al.
Nature Cardiovascular Research|August 28, 2024
A transcriptional enhancer regulates cardiac maturationMyo Htet, Shunyao Lei, Sheetal Bajpayi, et al.
Research Square|February 7, 2023
[WITHDRAWN] Hexokinase-1 mitochondrial dissociation and protein O-GlcNAcylation drive heart failure with preserved ejection fractionYuki Tatekoshi, Jason S Shapiro, Mingyang Liu, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 10, 2018
Elimination or neutralization of endogenous high-molecular-weight FGF2 mitigates doxorubicin-induced cardiotoxicityNavid Koleini, Jon-Jon Santiago, Barbara E Nickel, et al.
Pageof 4